患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Not recruiting

• Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558
• Melanoma (Skin)
• United States
• 2010-08-05

• Not recruiting

• Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects
• Influenza;Influenza;Influenza;Influenza
• Colombia, Panama, Philippines, United States
• 2010-07-13

• Not recruiting

• Sleep Intervention for Youth With Type 1 Diabetes
• Diabetes
• United States
• 2012-11-29

• Not recruiting

• A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
• Hepatocellular Carcinoma
• France, United States
• 2012-11-20

• Not recruiting

• Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects
• Chronic Hepatitis C Virus;Chronic Hepatitis C Virus;Chronic Hepatitis C Virus;Chronic Hepatitis C Virus
• United States
• 2012-11-10

• Not recruiting

• Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis
• Primary Amyloidosis;Primary Amyloidosis
• United States
• 2012-10-11

• Not recruiting

• Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar Formation
• Follow up to Acute Wound Scar Study
• United States
• 2012-10-09

• Not recruiting

• 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
• High Risk MC4R Genotype;Low Risk MC4R Genotype;One Week or Less Antipsychotic Lifetime Exposure;High Risk MC4R Genotype;Low Risk MC4R Genotype;One Week or Less Antipsychotic Lifetime Exposure;High Risk MC4R Genotype;Low Risk MC4R Genotype;One Week or Less Antipsychotic Lifetime Exposure;High Risk MC4R Genotype;Low Risk MC4R Genotype;One Week or Less Antipsychotic Lifetime Exposure
• United States
• 2013-04-29

• Not recruiting

• Safety, Tolerability and Efficacy of 12-weeks of Sovaprevir, ACH-3102 and Ribavirin in Treatment-naive GT-1 HCV Subjects
• Hepatitis C, Chronic;Hepatitis C, Chronic;Hepatitis C, Chronic;Hepatitis C, Chronic
• Canada, United States
• 2013-04-18

• Not recruiting

• Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors
• Solid Tumor;Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion Mutations;Tenosynovial Giant Cell Tumor
• United States
• 2013-03-01

• Not recruiting

• Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
• Proteinuria;Hypertension;Type II Diabetes;Proteinuria;Hypertension;Type II Diabetes;Proteinuria;Hypertension;Type II Diabetes
• United States
• 2013-03-01

• Not recruiting

• rTMS for Depressed Teens: A Sham-Controlled Trial, Part 1
• Major Depressive Disorder
• United States
• 2013-03-01

• Not recruiting

• A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
• Acute Respiratory Distress Syndrome
• United Kingdom, United States
• 2015-11-18

• Not recruiting

• Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection
• Hepatitis C, Chronic;Cirrhosis, Decompensated
• Canada
• 2015-11-03

• Not recruiting

• Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy Study
• Healthy Volunteers
• United States
• 2015-10-21

• Not recruiting

• ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1
• Atrial Fibrillation;Atrial Fibrillation;Atrial Fibrillation;Atrial Fibrillation
• United States
• 2015-10-05

• Not recruiting

• A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
• Unspecified Adult Solid Tumor, Protocol Specific
• United States
• 2016-08-03

• Not recruiting

• A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer
• Non-small Cell Lung Cancer (NSCLC)
• United States
• 2016-07-18

• Not recruiting

• Exercise Activity-Based Bolus Decisions in Type 1 Diabetes
• Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
• United States
• 2018-01-03

• Not recruiting

• Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment
• Hypercholesterolemia;Hypercholesterolemia;Hypercholesterolemia;Hypercholesterolemia
• Australia, Czech Republic, Czechia, France, Germany, Italy, Spain, United Kingdom, United States
• 2015-10-07